Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma

BACKGROUND: BCL2L13 belongs to the BCL2 super family, with its protein product exhibits capacity of apoptosis-mediating in diversified cell lines. Previous studies have shown that BCL2L13 has functional consequence in several tumor types, including ALL and GBM, however, its function in kidney cancer...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Cell Int
Auteurs principaux: Meng, Fei, Zhang, Luojin, Zhang, Mingjun, Ye, Kaiqin, Guo, Wei, Liu, Yu, Yang, Wulin, Zhai, Zhimin, Wang, Hongzhi, Xiao, Jun, Dai, Haiming
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Primary Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247248/
https://ncbi.nlm.nih.gov/pubmed/34193180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-02039-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires